Actimmune: ITMN started a U.S. Phase III trial of Actimmune in combination with carboplatin plus paclitaxel in 800 patients with advanced ovarian cancer. Actimm

InterMune Pharmaceuticals Inc. (ITMN), Brisbane, Calif. Product: Actimmune Business: Pulmonary Therapeutic category: Immune modulation Target: Unknown Description: Interferon gamma-1b Indication: Tre...